Doxinate

Quick links to important sections

Doxinate

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doxinate

What is Doxinate?

Doxinate is a prescription medication primarily used to manage nausea and vomiting during pregnancy, a condition often referred to as morning sickness. It is a combination therapy designed to provide relief when conservative management, such as dietary changes or lifestyle adjustments, has not been effective.

Composition and Mechanism

Doxinate typically consists of two active ingredients that work through different pathways to alleviate symptoms:

  • Doxylamine Succinate: This is an antihistamine. While often used for allergies or as a sleep aid, it is effective in treating nausea by affecting certain natural substances in the body that trigger the vomiting reflex.
  • Pyridoxine Hydrochloride (Vitamin B6): This is a water-soluble vitamin. Low levels of Vitamin B6 have been associated with increased nausea during pregnancy, and its supplementation is a recognized approach to improving these symptoms.

Therapeutic Use

The medication is formulated to help pregnant individuals maintain their nutritional intake and daily activities by reducing the frequency and severity of gastrointestinal distress. It is generally used when the symptoms are persistent enough to interfere with the patient's quality of life. The combination of an antihistamine and Vitamin B6 is utilized because the two components work together more effectively than either ingredient used alone for this specific indication.

Regulatory References

  1. MedlinePlus Drug Information on Doxylamine and Pyridoxine

What side effects are possible with Doxinate?

Possible Side Effects and Safety Information

Doxinate (doxylamine succinate and pyridoxine hydrochloride) is associated with a defined safety profile, primarily reflecting the effects of doxylamine, an antihistamine component.


Adverse Reactions and Safety Concerns

The most common adverse reaction reported in clinical trials is somnolence (drowsiness). Other frequently reported side effects include dry mouth, constipation, dizziness, and fatigue. These reactions are largely attributed to the anticholinergic properties of doxylamine.

Serious adverse reactions reported include severe drowsiness, which may lead to falls or accidents, especially when combined with other central nervous system (CNS) depressants. In cases of overdose, severe toxicity, including coma, seizures, cardiorespiratory arrest (particularly in children), and rhabdomyolysis, have been documented.


Safety Restrictions and Contraindications

  • Contraindications: Doxinate is contraindicated for use in individuals with known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, or pyridoxine hydrochloride. It is also contraindicated with the concurrent use of Monoamine Oxidase Inhibitors (MAOIs), which can prolong and intensify the anticholinergic effects.
  • Concomitant Medical Conditions: Caution is advised in patients with conditions that can be aggravated by anticholinergic effects, such as narrow-angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, and urinary bladder-neck obstruction.
  • Drug Interactions: Concurrent use with alcohol or other CNS depressants (e.g., sedatives, tranquilizers) is not recommended due to the potential for severe, additive drowsiness and sedation.
  • Breastfeeding: The use of this medication is generally not recommended while breastfeeding, as the components are likely excreted into breast milk and may cause adverse effects in the nursing infant, such as sedation or irritability.
  • Mental Alertness: Patients should avoid activities requiring complete mental alertness, such as driving or operating heavy machinery, until they know how the medication affects them.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Doxinate (Doxylamine succinate/Pyridoxine hydrochloride) requires immediate emergency attention due to the risk of severe complications, as documented in regulatory prescribing information.


Documented Manifestations of Overdose

Overdose effects are primarily related to the anticholinergic properties of doxylamine, which may escalate rapidly. Initial signs can include somnolence (extreme sleepiness), restlessness, vertigo, mental confusion, dry mouth, dilated pupils, and tachycardia (rapid heart rate).

Severe intoxication, as noted in official regulatory documents, can lead to life-threatening outcomes such as:

  • Seizures (convulsions)
  • Rhabdomyolysis (severe muscle breakdown)
  • Acute renal failure (kidney damage)
  • Coma and cardiorespiratory arrest (particularly noted in children)

Required Emergency Actions

The official prescribing information mandates specific actions in case of a suspected overdose:

  1. Seek emergency medical attention immediately.
  2. Contact a Poison Control center or call the local emergency number (e.g., 911).

Management in a clinical setting is symptomatic and supportive. Interventions may include considering gastric lavage or administration of activated charcoal. Hospital monitoring requires assessment of vital signs and checks for rhabdomyolysis by determining creatine kinase levels.

Population-Specific Risk

Official regulatory sources specifically note that the pediatric population is at a high risk for severe outcomes, including cardiorespiratory arrest and death, following doxylamine overdose.

Therapeutic Uses of Doxinate

The primary therapeutic scope of Doxinate (Doxylamine succinate/Pyridoxine Hydrochloride) is used to provide supportive symptomatic relief within specific clinical settings. It is commonly used across conditions presenting with acute or episodic manifestations, and may assist with managing the resulting patient discomfort. This combination is used for easing symptoms of Nausea and Vomiting of Pregnancy.

Managing Nausea and Vomiting of Pregnancy (NVP)

This medication is primarily used to address the symptomatic discomfort of Nausea and Vomiting of Pregnancy (morning sickness) in expectant mothers. Indications include symptoms related to persistent nausea, vomiting, and retching (dry heaves). It is applied when symptoms cluster into a pattern that creates noticeable interference with daily comfort. Relevant in contexts marked by increased discomfort or tension, it provides support that helps ease the overall burden of symptoms.

Relief of Persistent Sickness and Physical Retching

Doxinate is applied in addressing symptom clusters that may become intense or disruptive, such as persistent nausea and involuntary emesis. This support contributes to improved comfort during periods of heightened symptoms, which may assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Supportive relief for Nausea and Vomiting of Pregnancy (NVP).

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

Doxinate (Doxylamine succinate / Pyridoxine hydrochloride) is officially indicated for pregnant women whose symptoms of nausea and vomiting of pregnancy (NVP) have not been relieved by conservative management. Eligibility is strictly defined by regulatory documents.

Absolute Contraindications (Must Not Use):

The medicine is strictly contraindicated for patients with a known hypersensitivity or allergy to Doxylamine succinate, Pyridoxine, or other ethanolamine derivative antihistamines. It is also prohibited for patients concurrently taking Monoamine Oxidase Inhibitors (MAOIs), as this combination can intensify anticholinergic effects.

Restricted and Conditional Use:

  • Pediatric Patients: Use is not recommended in the pediatric population (under 18 years old), as safety and effectiveness have not been established.
  • Lactation: Use is generally not recommended during breastfeeding due to the potential for the drug to pass into breast milk.
  • Comorbidities: Caution is required for patients with pre-existing conditions that may be aggravated by the drug's anticholinergic properties, including asthma, narrow-angle glaucoma, and obstructive conditions of the gastrointestinal or urinary tracts. Caution is also advised for patients with hepatic or renal impairment.

What should I know about interactions with other medicines?

Doxinate Interactions with other medicines and products

This section describes the formally documented interaction patterns for the combination of Doxylamine succinate and Pyridoxine Hydrochloride, as outlined in official government regulatory documents.

Pharmacodynamic Interactions and Contraindications

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated, as MAOIs prolong and intensify the anticholinergic and adverse central nervous system effects of the antihistamine component. Concurrent use with other Central Nervous System (CNS) Depressants (including tranquilizers, sedatives, and alcohol) is not recommended due to the risk of severe drowsiness and potential accidents from additive CNS depression.

Drug and Diagnostic Test Interference

The use of this medicine may cause false positive results in urine screening tests for certain substances, specifically Methadone, Opiates, and Phencyclidine Phosphate (PCP). This potential for interference is an officially documented constraint related to diagnostic procedures.

Administration Timing and Absorption

Administration of the medication with food is documented to cause a further delay in the onset of action and a reduction in absorption of the active ingredients. As Pyridoxine Hydrochloride is a component of the drug, additional intake of Vitamin B6 supplements should also be assessed. Regulatory documents note that no data are available regarding the use or interaction severity in patients with hepatic or renal impairment.

Mechanism of Action

How Doxinate Works: Mechanism of Action

Doxinate operates through a combination of targeted molecular interactions to modulate the pathways that govern the emetic response.

Central H1 Receptor Blockade and Emetic Signaling

The primary mechanism involves Doxylamine succinate acting as an antagonist at histamine H1 receptors within the central nervous system (CNS). This molecular interaction suppresses the neural signaling transmission within the chemoreceptor trigger zone (CTZ) and the vomiting center in the medulla, thereby modulating the activity of emetic responses within the pathway.

Modulation of Peripheral and Vestibular Neural Pathways

Doxylamine also engages H1 receptors in peripheral areas, notably those associated with the vestibular system (balance mechanisms). This targeted pathway adjustment, complemented by a mild anticholinergic effect, reduces the signaling intensity of excessive neural activity originating from the inner ear's balance mechanisms.

Pyridoxine's Role in Mechanistic Cascade Regulation

Pyridoxine hydrochloride ( Vitamin B6) influences regulatory systems by functioning as a co-factor in numerous enzymatic reactions necessary for the synthesis of certain neurotransmitters (e.g., GABA and serotonin). Its mechanistic contribution supports a more regulated state within key neural signaling pathways, thereby modifying the resulting activity profile of Doxylamine's primary suppressive effects.

Dosage and Administration Information

How to Use Doxinate: Official Administration Guidelines

The usage of Doxinate (doxylamine succinate and pyridoxine hydrochloride) is governed by a structured, daily protocol intended for oral administration. This medicine is formulated as a delayed-release tablet and must be used as a scheduled prescription, not on an “as-needed” basis, to ensure consistent support.


Administration and Dosing Schedule

The standard regimen begins with a starting dose of two tablets (20 mg doxylamine/20 mg pyridoxine) taken at bedtime. Dosing recommendations may vary; the following regimen reflects a structured titration process.

Usage Feature Official Instruction
Route of Administration Oral use only.
Starting Dose (Day 1) Two tablets (20 mg/20 mg) at bedtime.
Titration Pattern Dose may be increased over subsequent days (up to Day 4) to a maximum of four tablets daily (40 mg/40 mg), split across morning, mid-afternoon, and bedtime doses.
Maximum Dose Four tablets (40 mg/40 mg) in a 24-hour period.

Contextual Instructions and Duration

To preserve the delayed-release properties of the tablet, Doxinate must be swallowed whole and must not be crushed, chewed, or split. The medication should be taken on an empty stomach with water.

Regarding the duration of use, the need for continued treatment is typically reassessed as the pregnancy progresses. When discontinuing the medication, a gradual tapering dose is recommended to help prevent the sudden return of symptoms. Safety and efficacy have not been established for individuals under 18 years of age.

Recent Clinical Evidence

Doxinate: Recent Clinical Evidence

The combination of doxylamine succinate (an antihistamine) and pyridoxine hydrochloride (Vitamin B6), often referred to by the trade name Doxinate in some regions, is frequently used to manage nausea and vomiting of pregnancy (NVP) that has not responded to conservative methods.

Efficacy and Symptom Improvement

  • Key Trial Data: The pivotal randomized controlled trial (RCT) supporting the current use of this combination compared it to a placebo in pregnant women with NVP. Over the 15-day treatment period, those receiving the combination demonstrated a statistically significant, albeit small, greater average improvement in NVP symptoms compared to the placebo group, as measured by the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score.
  • Comparative Studies: Some trials comparing the doxylamine-pyridoxine combination to other antiemetic agents have suggested that other treatments may lead to a greater reduction in nausea severity in some women, though results for vomiting improvement have varied between studies. There is limited high-quality evidence to definitively establish superiority over all other antiemetics.

Safety Profile and Risk Considerations

Clinical evidence gathered over many years suggests a favorable fetal safety profile for the doxylamine-pyridoxine combination. It is one of the few medications used in pregnancy that has been designated a Pregnancy Category A by some regulatory bodies, based on the lack of demonstrated risk to the fetus in controlled human studies during the first trimester and later.

Commonly Reported Effects: The most frequent side effects reported in clinical studies relate to the sedating properties of the doxylamine component, which may include drowsiness and somnolence. Other reported effects may include dry mouth and fatigue. Patients are often advised to monitor their alertness, especially when starting treatment.

Primary Endpoint Result Summary Key Finding
NVP Symptom Score (PUQE) Statistically significant greater mean reduction compared to placebo. Small but demonstrated symptom improvement.
Fetal Safety (Teratogenicity) Extensive epidemiological studies show no increased risk of congenital anomalies. Favorable fetal safety profile.

Frequently Asked Questions (FAQ)

Common questions about Doxinate (FAQ)

Q: How long after taking Doxinate should I wait before driving?

A: Official warnings state that due to the potential for drowsiness or somnolence, individuals must avoid engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery. A person must wait until they know exactly how the medication affects their body's alertness and coordination before attempting such activities.

Q: Are there any specific supplements or vitamins that should be avoided with Doxinate?

A: Regulatory documents recommend that individuals review all supplements, vitamins, and herbal products with a healthcare provider prior to use. This review is essential to identify any potential interactions or overlap with the drug’s active components, such as Pyridoxine (Vitamin B6).

Q: What is the difference between Doxinate and Vitamin B6 (Pyridoxine)?

A: Doxinate is a fixed-dose combination product that contains two active ingredients: the antihistamine doxylamine succinate, and the Vitamin B6 analog pyridoxine hydrochloride. The regulatory indication is specifically for the use of this combination, not for the use of Vitamin B6 alone.

Q: Can men use Doxinate?

A: Official regulatory documents state that the drug is indicated specifically for the treatment of nausea and vomiting of pregnancy in women who have not responded to conservative management. The safety and efficacy of the drug have not been established or assessed for use in the male population.

Q: What does 'teratogenicity' mean regarding Doxinate's safety class?

A: The term 'teratogenicity' refers to the potential for a drug to cause harm to a developing fetus. The combination drug's favorable classification in some official systems is based on extensive epidemiological studies that have not demonstrated a consistent or increased risk of congenital anomalies.

Q: Does Doxinate interfere with sleep, or can it help with sleep?

A: The drug is dosed at bedtime as part of a regimen to help control morning symptoms. Regulatory documents cite drowsiness or somnolence as the most common adverse reaction, which is a known effect of the antihistamine component. However, the official purpose of the drug is anti-nausea treatment, not a sleep aid.

Q: How quickly should I expect Doxinate to start working?

A: The drug is formulated as a delayed-release tablet, meaning its contents are released slowly in the body. Regulatory information indicates the drug is designed to start working approximately 4 to 6 hours after a dose is taken to manage symptoms expected the following morning.

Q: Can Doxinate be taken with anti-nausea medications?

A: Official documents recommend that all co-administered medications be reviewed with a healthcare provider. The product information specifically notes that co-administration with other Central Nervous System (CNS) depressants is not recommended due to the potential for severe drowsiness.

Q: Is Doxinate the same as other medications used for morning sickness?

A: Doxinate is a unique combination of an antihistamine (doxylamine succinate) and Vitamin B6 (pyridoxine). While it is classified as an antiemetic, other medications used for morning sickness may belong to different drug classes or contain different active ingredients.

Q: How long does the effect of one dose of Doxinate last?

A: The drug is designed as a delayed-release tablet for sustained and consistent delivery of the medication. This formulation helps manage symptoms over an extended period, which is why a single dose taken at night can still be effective into the following morning.

Q: What happens if I forget to take a dose of Doxinate?

A: The official regulatory instructions state that the missed dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular schedule continued. The instructions also state that extra medicine should not be taken to make up for a missed dose.

Q: What are the inactive ingredients in Doxinate tablets?

A: The full list of inactive ingredients is contained in the official prescribing information for the drug, such as the FDA-approved labeling. This is done to aid in the identification of known allergens or contraindications.

Q: Can Doxinate be taken with herbal remedies?

A: Regulatory documents recommend that all herbal products being taken or planned to take be reviewed with a healthcare provider. This ensures a proper review of any potential interactions or effects on the medication.

Q: Is Doxinate used for anything other than its main approved purpose?

A: The official regulatory indication for this drug is strictly the treatment of nausea and vomiting of pregnancy (NVP) in women who have not responded to conservative management. Regulatory documents do not address or recommend use for any other condition.

Q: Does Doxinate cause weight gain or loss?

A: Regulatory safety information includes postmarketing reports of increased appetite and weight gain associated with the antihistamine component of the drug.

Q: Does Doxinate affect blood pressure?

A: Regulatory safety documents note that hypotension (low blood pressure) is a reported adverse effect, which has primarily been observed in cases of hypersensitivity to the drug.

Q: Is Doxinate habit-forming or addictive?

A: Regulatory safety documents for this class of antihistamines note that the doxylamine component may be prone to abuse. The medication is intended for use strictly as directed by a healthcare provider.

Q: Is Doxinate considered a newer or older medication?

A: The fixed-dose combination of doxylamine and pyridoxine has a long history. Official documents note that the product was first introduced in the UK in the late 1950s.

Q: Is Doxinate approved in countries outside of the US?

A: Yes, the combination of doxylamine and pyridoxine has been reviewed and approved by regulatory bodies in several other countries, including those in the UK and Canada, for the treatment of nausea and vomiting of pregnancy.

How should Doxinate be stored and disposed of?

How to Store and Dispose of Doxinate

Doxinate (doxylamine succinate and pyridoxine hydrochloride) must be stored and handled according to official regulatory guidelines to maintain its stability and ensure safety.

Storage Requirements

Condition Regulatory Rule
Temperature Store at 25 C (77 F); keep at Controlled Room Temperature, permitting excursions between 15 C and 30 C (59 F and 86 F).
Protection Keep from freezing, and protect from moisture, heat, and direct light.
Container Store in the original, tightly closed container.
Safety Keep out of the reach and sight of children.

Disposal Instructions

Official instructions require patients to dispose of unused or expired medicine properly. Do not flush Doxinate down a toilet or pour it into a drain. Consult a pharmacist or utilize a community drug take-back program for the recommended method of disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Doxinate found in:

A-Z Index: